News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Fresenius Kabi AG Release: Diprivan® (Propofol) Injectable Emulsion, USP Now Available In 10 Ml Vials



8/11/2014 8:52:22 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today it has introduced Diprivan® (propofol) injectable emulsion in 10 mL single patient infusion vials. Diprivan is an intravenous sedative-hypnotic agent for use in the induction and maintenance of anesthesia or sedation and is one of the most widely used anesthesia products in the United States. Fresenius Kabi is a global health care company that specializes in life-saving medicines and technologies for infusion, transfusion and clinical nutrition.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES